The story of the erectile dysfunction drug presents a complex picture for investors. While the initial release generated substantial returns, the lapse of its exclusive rights opened the door to cheaper competitors, https://kobiekor597089.thekatyblog.com/39943000/viagra-and-big-pharma-a-precarious-investment